Developing Nanotechnique-Based Diagnostics for Obesity-Associated Liver Disease using Circulating Hepatocyte-Derived Extracellular Vesicle Biomarkers

Medicine & Life Sciences

1. Extracellular Vesicles 100%
2. Non-alcoholic Fatty Liver Disease 91%
3. Liver Diseases 71%
4. Hepatocytes 71%
5. Obesity 59%
6. Biomarkers 55%
7. Liver 16%
8. Biopsy 10%
9. Fibrosis 6%
10. Bariatric Surgery 6%
11. Costs and Cost Analysis 5%
12. Wounds and Injuries 5%